Skip to content

Company information lookup


The Company is a specialist medical diagnostics company focused on the development, manufacture and commercialisation of a range of in vitro diagnostic tests for point-of-care use.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
UBI 0.145 -9.38% 0.145 0.150 0.145 0.155 0.145 40,000


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code UBI
Official Listing Date 13 December, 2006
GICS Industry Group Health Care Equipment & Services
Exempt Foreign? No
Internet Address
Registered Office Address 1 Corporate Avenue, Rowville, VIC, AUSTRALIA, 3178
Head Office Telephone (03) 9213 9000
Head Office Fax (03) 9213 9099
Share Registry Telephone (02) 9290 9600
Directors / Senior Management
Mr Andrew Denver (Chairman, Director)
Mr Paul Wright (Managing Director, CEO)
Mr Denis Hanley (Director)
Mr Marshall Heinberg (Director)
Mr Andrew Jane (Director)
Mr Chris Smith (Director)
Mr Salesh Balak (CFO)
Mr Cameron Billingsley (External Advisor)
Company Secretary Mr Cameron Billingsley
Principal Activities The Company is a specialist medical diagnostics company focused on the development, manufacture and commercialisation of a range of in vitro diagnostic tests for point-of-care use.


How are company announcements published on

Date Price
Headline Pages PDF
16/10/2014 asterix Appendix 4C - Q3 2014 6 PDF
17/09/2014 asterix Delay to launch of new PT-INR testing system 2 PDF
01/09/2014 asterix Receives $8M R&D tax refund 1 PDF
18/08/2014   Appendix 3B 11 PDF
08/08/2014   Appendix 3B 11 PDF
24/07/2014   UBI 1H 2014 Results Presentation 20 PDF
24/07/2014 asterix UBI Appendix 4D and Half Year Accounts 49 PDF
18/07/2014   Investor conference call - 1H FY14 Results 1 PDF
14/07/2014 asterix Appendix 4C - quarterly 6 PDF
24/06/2014 asterix First commercial order from Siemens for PT-INR test strips 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
24 Oct 2014 0.145 -9.38% 0.155 0.145 40,000
23 Oct 2014 0.160 6.67% 0.160 0.150 96,250
22 Oct 2014 0.150 0% 0.160 0.145 57,110
21 Oct 2014 0.150 0% 0.160 0.150 83,418
20 Oct 2014 0.150 -3.23% 0.160 0.150 285,050

* Volume of shares shown represents only those shares traded on ASX.

UNIVERSAL BIOSENSORS INC. price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security UBI. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security UBI

Warrants & Structured Products

No warrants & Structured Products are available over the security UBI